The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study
Aspirin/antiplatelet agents may have a role in primary cancer prevention in people living with NAFLD.
Authors
- David R. J. Riley (ORCID: https://orcid.org/0000-0002-0905-6524)
- Jason Wai‐Lok Poon
- Uazman Alam (ORCID: https://orcid.org/0000-0002-3190-1122)
- Theresa Hydes (ORCID: https://orcid.org/0000-0002-7768-6886)
- Cyril Sieberhagen (ORCID: https://orcid.org/0000-0002-1289-5492)
- Daniel James Cuthbertson (ORCID: https://orcid.org/0000-0002-6128-0822)
- Matthew Anson (ORCID: https://orcid.org/0000-0001-9991-7369)
- Alex E. Henney
- Gema H. Ibarbaru
Institutions
- University of Liverpool (GB)
- Aintree University Hospitals NHS Foundation Trust (GB)
- TriNetX (United States) (US)
Publication Details
- Journal
- BMC Medicine
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1186/s12916-024-03802-4
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.77